» Articles » PMID: 27927987

Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Dec 9
PMID 27927987
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

A central hallmark of Alzheimer's disease is the presence of extracellular amyloid plaques chiefly consisting of amyloid-β (Aβ) peptides in the brain interstitium. Aβ largely exists in two isoforms, 40 and 42 amino acids long, but a large body of evidence points to Aβ(1-42) rather than Aβ(1-40) as the cytotoxic form. One proposed mechanism by which Aβ exerts toxicity is the formation of ion channel pores that disrupt intracellular Ca homeostasis. However, previous studies using membrane mimetics have not identified any notable difference in the channel forming properties between Aβ(1-40) and Aβ(1-42). Here, we tested whether a more physiological environment, membranes excised from HEK293 cells of neuronal origin, would reveal differences in the relative channel forming ability of monomeric, oligomeric, and fibrillar forms of both Aβ(1-40) and Aβ(1-42). Aβ preparations were characterized with transmission electron microscopy and thioflavin T fluorescence. Aβ was then exposed to the extracellular face of excised membranes, and transmembrane currents were monitored using patch clamp. Our data indicated that Aβ(1-42) assemblies in oligomeric preparations form voltage-independent, non-selective ion channels. In contrast, Aβ(1-40) oligomers, fibers, and monomers did not form channels. Ion channel conductance results suggested that Aβ(1-42) oligomers, but not monomers and fibers, formed three distinct pore structures with 1.7-, 2.1-, and 2.4-nm pore diameters. Our findings demonstrate that only Aβ(1-42) contains unique structural features that facilitate membrane insertion and channel formation, now aligning ion channel formation with the differential neurotoxic effect of Aβ(1-40) and Aβ(1-42) in Alzheimer's disease.

Citing Articles

The p3 peptides (Aβ) rapidly form amyloid fibrils that cross-seed with full-length Aβ.

Tian Y, Torres-Flores A, Shang Q, Zhang H, Khursheed A, Tahirbegi B Nat Commun. 2025; 16(1):2040.

PMID: 40016209 PMC: 11868391. DOI: 10.1038/s41467-025-57341-4.


Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses.

Kadamangudi S, Marcatti M, Zhang W, Fracassi A, Kayed R, Limon A Acta Neuropathol. 2024; 149(1):2.

PMID: 39688618 PMC: 11652575. DOI: 10.1007/s00401-024-02839-2.


Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies.

Cehlar O, Njemoga S, Horvath M, Cizmazia E, Bednarikova Z, Barrera E Int J Mol Sci. 2024; 25(23).

PMID: 39684761 PMC: 11641156. DOI: 10.3390/ijms252313049.


Membrane-assisted Aβ40 aggregation pathways.

Muhammedkutty F, Zhou H bioRxiv. 2024; .

PMID: 39282376 PMC: 11398458. DOI: 10.1101/2024.09.05.611426.


Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models.

Marcatti M, Tumurbaatar B, Borghi M, Guptarak J, Zhang W, Krishnan B Int J Mol Sci. 2024; 25(16).

PMID: 39201779 PMC: 11354963. DOI: 10.3390/ijms25169092.


References
1.
Hirakura Y, Lin M, Kagan B . Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res. 1999; 57(4):458-66. View

2.
Lin H, Zhu Y, Lal R . Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. Biochemistry. 1999; 38(34):11189-96. DOI: 10.1021/bi982997c. View

3.
Mayeux R, Tang M, Jacobs D, Manly J, Bell K, Merchant C . Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol. 1999; 46(3):412-6. DOI: 10.1002/1531-8249(199909)46:3<412::aid-ana19>3.0.co;2-a. View

4.
Klein A, Kowall N, Ferrante R . Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex. Ann N Y Acad Sci. 2000; 893:314-20. DOI: 10.1111/j.1749-6632.1999.tb07845.x. View

5.
Naslund J, Haroutunian V, Mohs R, Davis K, Davies P, Greengard P . Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 2000; 283(12):1571-7. DOI: 10.1001/jama.283.12.1571. View